Benefícios da adubação verde sobre a simbiose micorrízica e a produtividade de batata-doce.

Plantio das leguminosas e da batata doce. Produtividade da batata doce e simbiose micorrízica.bitstream/CNPAB-2010/27139/1/cot014.pd

Balanço de nutrientes em cultivos de hortaliças sob manejo orgânico.

bitstream/CNPAB-2010/27146/1/cot021.pd

Avaliação do consórcio de cenoura com alface em sistema orgânico de produção.

bitstream/CNPAB-2010/27142/1/cot017.pd

Adubação verde: Estratégia para uma agricultura sustentável.

Efeitos da adubação verde nas características do solo. Efeitos químicos. Efeitos físicos. Efeitos biológicos. Fixação biológica de nitrogênio. Decomposição dos resíduos vegetais. Comportamento ecofisiologico dos adubos verdes. Condições edáficas. Seleção de leguminosas para a adubação verde. Formas de utilização dos adubos verdes.bitstream/CNPAB-2010/27233/1/doc042.pd

Estratégias para utilização de leguminosas para adubação verde em unidades de produção agroecológica.

Efeitos da adubação verde nos agroecossistemas. Escolha de leguminosas para a adubação verde. Leguminosas adaptadas às baixadas úmidas. Leguminosas adaptadas às condições de frio. Leguminosas adaptadas às condições de reduzida umidade do solo. Leguminosas adaptadas às condições de baixa fertilidade do solo. Formas de utilização dos adubos verdes. Cultivo prévio da leguminosa anual, seguido do plantio da cultura econômica anual. Consórcio de leguminosa anual ou perene com a cultura econômica anual. Consórcio de leguminosa perene com a cultura econômica perene. Cultivo em faixas intercalares de leguminosas semi-perene ou arbórea com cultura econômica anual ou perene.bitstream/CNPAB-2010/32095/1/doc174.pd

Promoting academic development through situated critical reflection

Many changes in higher education derived from Europe-wide initiatives such as the Bologna process have given increasing attention to student-centred teaching approaches, allied to growth in teachers’ academic development (Clarke & Reid, 2013; HE Academy, 2011). Our study is one component of a long-standing project focused on ways to promote academic development in the context of higher education. Work since 2001 has provided a strong understanding of the dynamics of student-generated questioning, inquiry-based learning and academic practices (Pedrosa de Jesus, Lopes, Moreira & Watts, 2012)

Quality of Life of Patients with Type 1 Diabetes Mellitus Using Insulin Analog Glargine Compared with NPH Insulin: A Systematic Review and Policy Implications

INTRODUCTION: Insulin analogue glargine (GLA) has been available as one of the therapeutic options for patients with type 1 diabetes mellitus to enhance glycemic control. Studies have shown that a decrease in the frequency of hypoglycemia episodes improves the Quality of Life (QoL) of diabetic patients. However, there are appreciable acquisition cost differences between different insulins. Consequently, a need to assess their impact on QoL to provide future guidance to health authorities. METHOD: A Systematic review (SR) of multiple databases including Medline, LILACS, Cochrane and EMBASE databases with several combinations of agreed terms involving randomized controlled trials (RCTs) and cohorts, as well as manual searches and gray literature was undertaken. The primary outcome measure was a change in QoL. The quality of the studies and the risk of bias was also assessed. RESULTS: Eight studies were eventually included in the systematic review out of 634 publications. Eight different QoL instruments were used (2 generic, 2 mixed and 4 specific), in which the Diabetes Treatment Satisfaction Questionnaire (DTSQs) was the most used. The systematic review did not consistently show any significant difference overall in QoL scores whether as part of subsets or combined into a single score with the use of GLA versus NPH insulin. Only in patients’ satisfaction measured by DTSQ was a better result consistently seen with GLA versus NPH insulin but not using the WED scale. However, none of the cohort studies scored a maximum on the Newcastle-Ottawa scale for quality and they generally were of moderate quality with bias in the studies. CONCLUSION: There was no consistent difference in QoL or patient reported outcomes when the findings from the eight studies were collated. In view of this, we believe the current price differential between GLA and NPH insulin in Brazil cannot be justified by these findings